Cross Country Healthcare, Inc. - stock earnings
CCRN Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 1, 2024 AfterMarket | 0.19 / 0.17 | - | 379.2 million / 381.6 million | - |
| July 31, 2024 BeforeMarket | - / - | 331.1 million | - / 342.2 million | 362.2 million |
CCRN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 2.7 million USD | 379.2 million USD |
| 2023Q4 | 9.0 million USD | 414.0 million USD |
| 2023Q3 | 12.8 million USD | 442.3 million USD |
| 2023Q2 | 21.3 million USD | 540.7 million USD |
| 2023Q1 | 29.4 million USD | 622.7 million USD |
| 2022Q4 | 38.8 million USD | 628.2 million USD |
| 2022Q3 | 34.8 million USD | 636.1 million USD |
| 2022Q2 | 52.9 million USD | 753.6 million USD |
| 2022Q1 | 62.0 million USD | 788.7 million USD |
| 2021Q4 | 77.6 million USD | 640.7 million USD |
| 2021Q3 | 23.4 million USD | 374.9 million USD |
| 2021Q2 | 11.5 million USD | 331.8 million USD |
| 2021Q1 | 19.4 million USD | 329.2 million USD |
| 2020Q4 | 4.6 million USD | 215.6 million USD |
| 2020Q3 | -1.3 million USD | 194.0 million USD |
| 2020Q2 | -14.2 million USD | 216.8 million USD |
| 2020Q1 | -2.1 million USD | 210.1 million USD |
| 2019Q4 | -1.1 million USD | 215.1 million USD |
| 2019Q3 | -3.1 million USD | 209.2 million USD |
| 2019Q2 | -51.7 million USD | 202.8 million USD |
| 2019Q1 | -1.8 million USD | 195.2 million USD |
| 2018Q4 | -19.7 million USD | 200.9 million USD |
| 2018Q3 | -441000 USD | 200.7 million USD |
| 2018Q2 | 1.5 million USD | 204.6 million USD |
| 2018Q1 | 1.6 million USD | 210.3 million USD |
| 2017Q4 | 28.0 million USD | 219.7 million USD |
| 2017Q3 | 6.7 million USD | 228.5 million USD |
| 2017Q2 | 4.9 million USD | 209.3 million USD |
| 2017Q1 | -2.0 million USD | 207.6 million USD |
| 2016Q4 | -7.9 million USD | 222.5 million USD |
| 2016Q3 | 14.1 million USD | 215.0 million USD |
| 2016Q2 | -17.2 million USD | 199.4 million USD |
| 2016Q1 | 19.0 million USD | 196.6 million USD |
| 2015Q4 | -6.1 million USD | 193.1 million USD |
| 2015Q3 | 5.0 million USD | 195.7 million USD |
| 2015Q2 | 2.6 million USD | 192.6 million USD |
| 2015Q1 | 2.9 million USD | 186.0 million USD |
| 2014Q4 | -20.2 million USD | 188.1 million USD |
| 2014Q3 | -7.6 million USD | 188.9 million USD |
| 2014Q2 | -3.2 million USD | 122.7 million USD |
| 2014Q1 | -782000 USD | 118.1 million USD |
| 2013Q4 | -35.2 million USD | 109.2 million USD |
| 2013Q3 | 914000 USD | 108.0 million USD |
| 2013Q2 | -1.5 million USD | 110.8 million USD |
| 2013Q1 | 1.2 million USD | 110.3 million USD |
| 2012Q4 | -9.5 million USD | 111.7 million USD |
| 2012Q3 | -17.6 million USD | 129.1 million USD |
| 2012Q2 | -14.5 million USD | 126.3 million USD |
| 2012Q1 | -584000 USD | 126.7 million USD |
| 2011Q4 | 531849 USD | 124.7 million USD |
| 2011Q3 | 1.8 million USD | 131.2 million USD |
| 2011Q2 | 1.6 million USD | 126.0 million USD |
| 2011Q1 | 207000 USD | 122.0 million USD |
| 2010Q4 | -6.0 million USD | 113.7 million USD |
| 2010Q3 | 916000 USD | 115.7 million USD |
| 2010Q2 | 1.2 million USD | 117.8 million USD |
| 2010Q1 | 1.1 million USD | 121.4 million USD |
| 2009Q4 | 398308 USD | 124.1 million USD |
| 2009Q3 | 968000 USD | 129.6 million USD |
| 2009Q2 | 2.3 million USD | 149.0 million USD |
| 2009Q1 | 3.0 million USD | 175.4 million USD |
| 2008Q4 | -161.3 million USD | 205.9 million USD |
| 2008Q3 | 6.2 million USD | 178.1 million USD |
| 2008Q2 | 6.4 million USD | 171.0 million USD |
| 2008Q1 | 5.9 million USD | 179.3 million USD |
| 2007Q4 | 7.3 million USD | 181.7 million USD |
| 2007Q3 | 7.0 million USD | 185.1 million USD |
| 2007Q2 | 5.5 million USD | 175.3 million USD |
| 2007Q1 | 4.8 million USD | 176.1 million USD |
| 2006Q4 | 7.5 million USD | 175.7 million USD |
| 2006Q3 | 122000 USD | 162.9 million USD |
| 2006Q2 | 4.4 million USD | 156.7 million USD |
| 2006Q1 | 4.6 million USD | 159.8 million USD |
| 2005Q4 | 4.9 million USD | 165.8 million USD |
| 2005Q3 | 5.0 million USD | 162.6 million USD |
| 2005Q2 | 1.2 million USD | 159.0 million USD |
| 2005Q1 | 3.6 million USD | 158.0 million USD |
| 2004Q4 | 5.6 million USD | 149.1 million USD |
| 2004Q3 | 5.1 million USD | 165.1 million USD |
| 2004Q2 | 5.1 million USD | 167.3 million USD |
| 2004Q1 | 4.9 million USD | 172.6 million USD |
| 2003Q4 | 5.1 million USD | 175.6 million USD |
| 2003Q3 | 6.8 million USD | 184.4 million USD |
| 2003Q2 | 6.8 million USD | 165.9 million USD |
| 2003Q1 | 7.1 million USD | 161.0 million USD |
| 2002Q4 | 8.9 million USD | 171.5 million USD |
| 2002Q3 | 5.9 million USD | 157.7 million USD |
| 2002Q2 | 8.0 million USD | 156.0 million USD |
| 2002Q1 | 7.0 million USD | 154.9 million USD |
| 2001Q4 | 2.1 million USD | 144.3 million USD |
| 2001Q3 | 3.9 million USD | 133.5 million USD |
| 2001Q2 | 1.3 million USD | 111.4 million USD |
| 2001Q1 | 1.3 million USD | 111.4 million USD |
| 2000Q4 | 1.3 million USD | 97.2 million USD |
| 2000Q3 | 1.5 million USD | 92.8 million USD |
| 2000Q2 | 891000 USD | 88.1 million USD |
| 2000Q1 | 901000 USD | 89.6 million USD |
CCRN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 72.6 million USD | 2.0 billion USD |
| 2022 | 188.5 million USD | 2.8 billion USD |
| 2021 | 132.0 million USD | 1.7 billion USD |
| 2020 | -12.1 million USD | 836.4 million USD |
| 2019 | -55.9 million USD | 822.2 million USD |
| 2018 | -17.0 million USD | 816.5 million USD |
| 2017 | 37.5 million USD | 865.0 million USD |
| 2016 | 8.0 million USD | 833.5 million USD |
| 2015 | 4.4 million USD | 767.4 million USD |
| 2014 | -31.8 million USD | 617.8 million USD |
| 2013 | -34.6 million USD | 438.3 million USD |
| 2012 | -42.2 million USD | 442.6 million USD |
| 2011 | 4.1 million USD | 504.0 million USD |
| 2010 | -2.8 million USD | 468.6 million USD |
| 2009 | 6.7 million USD | 578.2 million USD |
| 2008 | -142.9 million USD | 734.2 million USD |
| 2007 | 24.6 million USD | 718.3 million USD |
| 2006 | 16.6 million USD | 655.2 million USD |
| 2005 | 14.8 million USD | 645.4 million USD |
| 2004 | 20.7 million USD | 654.1 million USD |
| 2003 | 25.8 million USD | 686.9 million USD |
| 2002 | 29.8 million USD | 640.0 million USD |
| 2001 | 8.7 million USD | 500.5 million USD |
| 2000 | 4.6 million USD | 367.7 million USD |
| 1999 | 11.5 million USD | 193.8 million USD |
CCRN
Price: $16.67
52 week price:
Payout Ratio Range:
Earnings Per Share: 2.05 USD
P/E Ratio: 7.16
Exchange: NMS
Sector: Healthcare
Industry: Medical Care Facilities
Volume: 717600
Ebitda: 11.3 millionMarket Capitalization: 582.1 million